Imports of consignments of semen of equidae collected in accordance with Directive 92/65 after 30 September 2014 and dispatched from an approved semen collection centre of origin of the semen GBHC810 v1.0 Aug-23
Part I. Details of dispatched consignment GERMINAL
I.1 Consignor Name: Address: Tel:	I.2 Certificate reference no.	I.3. Central competent authority Department of Agriculture, Fisheries and Forestry
RME-00
I.2.a Not in use	I.4. Local competent authority Department of Agriculture, Fisheries and Forestry
I.5. Consignee Name: Address: Tel:	I.6 Person responsible for the load in Great Britain Name: Address: Tel:
I.7. Country of origin	ISO code	I.8. Region of Origin	Code	I.9. Country of destination	ISO Code	I.10. Region of destination	Code
Australia	AU	UNITED KINGDOM	GB
I.11. Place of origin	I.12. Place of destination
Semen centre Name: Approval number: Address:	Semen centre Holding Name: Address:
I.13. Place of loading XXXXXXXX, AUSTRALIA	I.14. Date of departure DD/MM/YYYY
I.15. Means of transport	I.16. Entry BCP [Border Control Post]
Aeroplane Ship Railway wagon Road vehicle Other Identification: Flights: XXXXXX Documentation references: MAWB: XXXXXX	XXXXXXX
I.17. Not in use
I.18 Description of commodity EQUINE FROZEN SEMEN
I.19 Commodity code (HS code) 05 11 99 85	I.21 Not in use	I.23 Seal / Container No. XXXXXX / XXXXXXXXXXX
I.20 Quantity: # straws	I.22 Number of packages: # cryogenic containers	I.24 Not in use
I.25 Commodity certified for: Artificial reproduction
I.26  For transit through Great Britain to third country Third country: ISO Code:	I.27 For import or admission into Great Britain
I.28. Identification of the commodities
Species (Scientific name)	Donor identity	Date of collection	Quantity
See attachment 1

Part II. Certification

Animal Health

I, the undersigned centre veterinarian, hereby declare that:

AH/E351F Establishment requirement (Collection centre)

The semen collection centre, in which the semen described above was collected, processed and stored for export to Great Britain is approved and supervised by the competent authority in accordance with GB requirements;

AH/E605A Establishment requirements (freedom from disease)

during the period commencing 30 days prior to the date of first collection of the semen described above until the date the fresh or chilled semen was dispatched or until the 30 days storage period for frozen semen elapsed, the semen centre:

(a) It is situated in the exporting country or, in the case of regionalisation according to GB requirements, in that part of the territory of the exporting country which was:

(i) not considered to be infected with African horse sickness as per GB requirements,

(ii) free from Venezuelan equine encephalomyelitis for a period of at least 2 years,

(iii) free from glanders and dourine for a period of at least 6 months

(b) fulfilled the conditions for a holding as per GB requirements and in particular:

(*) EITHER (i) following a case of a disease mentioned below not all the animals of species susceptible to that disease located in the holding were slaughtered or killed and the holding has been free from any type of equine encephalomyelitis, equine infectious anaemia (EIA), vesicular stomatitis (VS), rabies, and anthrax as per GB requirements]

(*) OR (ii) [following a case of a disease mentioned below all the animals of species susceptible to that disease located in the holding have been slaughtered or killed and the premises disinfected, and the holding was free for a period of at least 30 days from any type of equine encephalomyelitis, equine infectious anaemia, vesicular stomatitis and rabies or 15 days in the case of anthrax, beginning on the day on which following the destruction of the animals the disinfection of the premises was

satisfactorily completed;]

(c) contained only equidae which were free of clinical signs of equine viral arteritis and contagious equine metritis,

AH/A725A Animal requirements

the semen described above was collected from donor stallions which:

(a) did not show any clinical sign of an infectious or contagious disease at the time of admission onto the semen collection centre and on the day the semen was collected;

(b) were kept for a period of at least 30 days prior to the date of semen collection in holdings where no equine animal has shown any clinical sign of equine viral arteritis or contagious equine metritis during that period;

(c) were not used for natural mating during a period of at least 30 days prior to the date of first semen collection and between the dates of the first sample referred to in points (e)(i), (e)(ii) and/or (e)(iii) of AH/A725A and until the end of the collection period;

(d) underwent the following tests, which meet at least the requirements of the relevant Chapter of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the WOAH, carried out in a laboratory that fulfils GB requirements, as follows:

(*) [(i) for equine infectious anaemia (EIA), as per GB requirements, an agar-gel immuno-diffusion test (AGID or Coggins test) or an enzyme-linked immunosorbent assay (ELISA) for equine infectious anaemia with a negative result;]

(ii) for equine viral arteritis (EVA)

(*) EITHER [(1) a serum neutralisation test with a negative result at a serum dilution of one in four;]

(*) AND/OR [(2) a virus isolation test, polymerase chain reaction (PCR) or real time PCR with a negative result on an aliquot of the entire semen of the donor stallion;]

(iii) for contagious equine metritis (CEM), as per GB requirements with a negative result to a test for:

(*) EITHER [the isolation of Taylorella equigenitalis after cultivation under microaerophilic conditions for a period of at least 7 days, set up within 24 hours after taking the specimens from the donor animal, or 48 hours where the specimens are kept cool during transport]

(*) AND/OR [the detection of genome of Taylorella equigenitalis by PCR or real-time PCR, carried out within 48 hours after taking the specimens from the donor animal]

(e) were subjected with the results specified in point (d) of AH/A725A in each case to at least one of the test programmes detailed in GB requirements and as follows:

(*) [(i) the donor stallion was continuously resident on the semen collection centre for a period of at least 30 days prior to the date of the first collection and during the period of collection of the semen described above, and no equidae on the semen collection centre came during that time into direct contact with equidae of lower health status than the donor stallion.

The tests described in point (d) were carried out as per GB requirements.]

(*) [(ii) The donor stallion was resident on the semen collection centre for a period of at least 30 days prior to the date of the first collection and during the period of collection of the semen described above, but left the semen collection centre under the responsibility of the centre veterinarian for a continuous period of less than 14 days, and/or other equidae on the semen collection centre came in to direct contact with equidae of a lower health status.

The tests described in point (d) were carried as per GB requirements,

and during the period of collection of the semen intended for imports into Great Britain of fresh, chilled or frozen semen the donor stallion was subjected to the tests described in point (d), as follows:

(1) for equine infectious anaemia, one of the tests described in point (d)(i) was last carried out on a sample of blood taken (Insert date in the table in point (f))not more than 90 days prior to the collection of the semen described above.

(2) for equine viral arteritis, one of the tests described

(*) EITHER [in point (d)(ii) was last carried out on a sample taken as per GB requirements;]

(*) OR [in point (d)(ii) (2) was carried out on an aliquot of the entire semen of the donor stallion taken as per GB requirements;]

(3) for contagious equine metritis, the test described in point (d)(iii) was last carried out as per GB requirements

(*) EITHER [on two occasions]

(*) OR [on a single occasion and subjected to a PCR or real-time PCR.]]

(*) [(iii) The donor stallion does not meet the conditions set out in GB requirements and the semen is collected for imports into Great Britain of frozen semen.

The tests described in points (d)(i), (d)(ii) and (d)(iii) were carried out as per GB requirements and;

(*) EITHER [the tests for equine viral arteritis described in point (d)(ii) were carried out as per GB requirements]

(*) OR [the non-shedder state of a donor stallion seropositive for equine viral arteritis was confirmed as per GB requirements]

(f) underwent the testing provided for in AH/A781A point (b) and AH/A725A points (d) and (e) on samples taken on the following dates:

Identification of semen	Test programme	Start Date	Date of sampling for health tests
Donor residence	Semen collection	(*) VS point (b) of AH/A781A	EIA point (d)(i) of AH/A725A	EVA point (d)(ii) of AH/A725A	CEM point (d)(iii) of AH/A725A
Blood sample	Semen sample	Semen sample 1	Semen sample 2

AH/A781A Animal requirements (freedom from disease)

Prior to entering the semen collection centre the donor stallions and any other equidae located in the centre:

(a) were continuously resident for a period of 3 months (or since entry if they were directly imported from Great Britain during the 3 months period) in the exporting country or, in the case of regionalisation as per GB requirements, in that part of the territory of the exporting country which was during that period:

(i) not considered to be infected with African horse sickness as per GB requirements,

(ii) free from Venezuelan equine encephalomyelitis for a period of at least 2 years,

(iii) free from glanders and dourine for a period of at least 6 months;

(b) Vesicular Stomatitis:

(*) EITHER [(i) originated from the country of export which was on the day of admission into the centre free from vesicular stomatitis (VS) for a period of at least 6 months,]

(*) OR [(ii) were subjected to a virus neutralisation test for vesicular stomatitis (VS) or a VS ELISA carried out as per GB requirements with a negative result on a blood sample taken within 14 days prior to entering the centre;]

(c) originated from holdings which on the day of admission onto the centre fulfilled the requirements of point (b) of AH/E605A Establishment requirements;

AH/P463 Product requirements

(*) EITHER (a) [No antibiotics were added to the semen.]

(*) OR (b) [The following antibiotic or combination of antibiotics was added to produce a concentration in the final diluted semen of not less than: ………………………………………………………………………………………………………………………]

AH/P551D Product requirements (storage and transport)

the semen described above was:

(a) collected, processed, stored and transported under conditions which comply with GB requirements;

(b) sent to the place of loading in a sealed container in accordance with GB requirements.

(*) Keep as appropriate.

Centre Veterinarian
By signing this certificate, I certify that the requirements laid out above and in the accompanying notes for completion have been met.
Name (in capital letters):	Qualification and title:
Date:
Stamp:	Signature: (PDF only)

Attachment 1

I.28. Identification of the commodities
Species (Scientific name)	Donor identity	Date of collection	Quantity

Part III. Notes for completion

These notes for completion must be read and understood by the certifying officer before signing the certificate. Notes are set out in sections that correspond to the sections in the certificate. By signing this certificate, certifiers are verifying that the consignment meets the requirements set out in the certificate and any relevant corresponding notes for completion.

These notes do not need to be printed as part of a paper certificate that accompanies the consignment or in any electronic copy of the certificate.

References to European Union legislation within this certificate are references to direct EU legislation which has been retained in Great Britain (retained EU law as defined in the European Union (Withdrawal) Act 2018) and can be viewed on the UK legislation website (legislation.gov.uk).

References to Great Britain in this certificate include Channel Islands and Isle of Man.

References to GB requirements refer to the requirement(s) of Great Britain as set out in the accompanying notes for completion.

Part I

Box reference I.11: The place of origin shall correspond to the semen collection centre of the semen origin.

Box reference I.22: The number of packages shall correspond to the number of containers.

Box reference I.23: The identification of container and seal number shall be indicated.

Box reference I.28: The donor identity shall correspond to the official identification of the animal.

The date of collection shall be indicated in the following format dd/mm/yyyy.

Part II

Animal Health

Imports of equine semen are authorised from a third country listed in column 2 as set out in a document relating to ‘equidae’ published on gov.uk, in accordance with Regulation 2018/659 provided that the semen was collected in the part of the territory of the third country detailed in column 4 of that document from a donor stallion of the category of Equidae indicated in columns 11, 12 or 13 of that document. (†)

AH/E351F Establishment requirement (Collection centre)

GB requirements:

The approved semen collection centres must be listed in accordance with Article 17(3)(b) of Directive 92/65.

The semen collection centre is approved and supervised by the competent authority in accordance with the conditions of the Chapters I(I)(1) and I(II)(1) of Annex D to Directive 92/65

This Directive lays down animal health requirements governing imports into Great Britain of animals, semen, ova and embryos not subject to animal health requirements laid down in legislation referred to in Annex F to the Directive

AH/E605A Establishment requirements (freedom from disease)

GB requirements:

(a) regionalisation according to Article 13 of Directive 2009/156, on animal health conditions governing the movement and importation from third countries of Equidae.

In regard to African Horse Sickness, it is not considered to be infected in accordance with Article 5(2)(a) and (b) of Directive 2009/156.

(b) Fulfilled the conditions for a holding laid down in Article 4(5) of Directive 2009/156.

(b) (i):

from any type of equine encephalomyelitis for a period of at least 6 months, beginning on the day on which the equidae suffering from the disease are slaughtered,

from equine infectious anaemia (EIA) for at least the period required to obtain a negative result in an agar gel immunodiffusion test ( AGID or Coggins test) carried out on samples taken after the infected animals were slaughtered on two occasions 3 months apart from each of the remaining animals,

from vesicular stomatitis (VS) for a period of at least 6 months from the last recorded case,

from rabies for a period of at least one month from the last recorded case

from anthrax for a period of at least 15 days from the last recorded case

AH/A725A Animal requirements

(d) Tests carried out in a laboratory which is recognised by the competent authority and has the tests included in its accreditation equivalent to that provided for in Article 37 of Regulation No 2017/625

(d)(i) The agar gel immunodiffusion test (AGID or Coggins test) or the ELISA for equine infectious anaemia are not required for donor equidae which have continuously resided in Iceland since birth, provided that Iceland has remained officially free of equine infectious anaemia and no equidae and their semen, ova and embryos have been introduced into Iceland from outside prior to and during the period the semen was collected.

(d)(iii) For contagious equine metritis (CEM), an agent identification test carried out on three specimens (swabs) taken from the donor stallion on two occasions with an interval of not less than 7 days at least from the penile sheath (prepuce), the urethra and the fossa glandis. The samples were in no case taken earlier than 7 days (systemic treatment) or 21 days (local treatment) after antimicrobial treatment of the donor stallion and were placed in transport medium with activated charcoal, such as Amies medium, before dispatch to the laboratory where they were subjected with a negative result to a test for Taylorella equigenitalis

(e) Test programmes detailed respectively in points 1.6 (a), (b) and (c) of Chapter II of Annex D to Directive 92/65

(e) (i) and (e) (ii)

The tests described in point (d) were carried out on samples taken Insert date in the table in point (f) (see guidance on completion of the table in point (f) at the end of the notes for completion) from the donor stallion at least once a year at the beginning of the breeding season or prior to the first collection of semen intended for imports into Great Britain of fresh, chilled or frozen semen and not less than 14 days following the date of the commencement of the residence period of at least 30 days prior to the first semen collection.

(e) (ii) (2) for the either option:

In point (d)(ii) was last carried out on a sample taken Insert date in the table in point (f) of this attestation Requirements not more than 30 days prior to the date of the collection of the semen described above.

(e) (ii) (2) for the or option:

In point (d)(ii)(2) either option was carried out on an aliquot of the entire semen of the donor stallion taken Insert date in the table in point (f) not more than 6 months prior to the date of the collection of the semen described above and a blood sample taken Insert date in the table in point (f) from the donor stallion during the 6 months period reacted with a positive result in a serum neutralisation test for equine viral arteritis at a serum dilution of more than one in four;

(e) (ii) (3):

For contagious equine metritis, the test described in point (d)(iii) was last carried out on three specimens (swabs) taken Insert date in the table in point (f) not more than 60 days prior to the date of the collection of semen described above

(e) (iii) The donor stallion does not meet the conditions set out in points 1.6(a) and (b) of Chapter II of Annex D to Directive 92/65 and the semen is collected for imports into Great Britain of frozen semen.

The tests described in points (d)(i), (d)(ii) and (d)(iii) were carried out on samples taken Insert date in the table in point (f) of this attestation from the donor stallion at least once a year at the beginning of the breeding season.

The tests described in points (d)(i) and (d)(iii) were carried out on samples taken Insert date in the table in point (f) from the donor stallion during the storage period of the semen of a minimum period of 30 days from the date of the collection of the semen and before the semen is removed from the semen collection centre, not less than 14 days and not more than 90 days after the collection of the semen described above.

(e) (iii) for the either option:

The tests for equine viral arteritis described in point (d) (ii) were carried out on samples taken Insert date in the table in point (f) of this attestation during the storage period of the semen of a minimum period of 30 days from the date of collection of the semen and before the semen is removed from the semen collection centre or used, not less than 14 days and not more than 90 days after the date of the collection of the semen described above.]

(e) (iii) for the or option:

The non-shedder state of a donor stallion seropositive for equine viral arteritis was confirmed by a virus isolation test, PCR or real-time PCR carried out with a negative result on samples of an aliquot of the entire semen of the donor stallion taken Insert date in the table in point (f) twice a year at an interval of at least 4 months and the donor stallion has reacted with a positive result at a serum dilution of at least one in four in a serum neutralisation test for equine viral arteritis.

Guidance for the completion of the table

Abbreviations:

VS Vesicular stomatitis (VS) testing if required in accordance with point (b) of AH/A781A

EIA-1 Equine infectious anaemia (EIA) testing first occasion

EIA-2 EIA testing second occasion

EVA-B1 Equine viral arteritis (EVA) testing on blood sample first occasion

EVA-B2 EVA testing on blood sample second occasion

EVA-S1 EVA testing on semen sample first occasion

EVA-S2 EVA testing on semen sample second occasion

CEM-11 Contagious equine metritis (CEM) testing first occasion first sample

CEM-12 CEM testing first occasion second sample taken 7 days after CEM-11

CEM-21 CEM testing second occasion first sample

CEM-22 CEM testing second occasion second sample taken 7 days afterCEM-21

Instructions:

For each semen identified in column A in correspondence with Box I.28, the test programme (points (e)(i) of this attestation, (e)(ii) of this attestation and/or (e)(iii) of this attestation) shall be specified in column B, and columns C and D shall be completed with the dates required.

The dates when samples were taken for laboratory testing prior to the first collection of the semen described above as required in points (e)(i) of this attestation, (e)(ii) of this attestation and (e)(iii) of this attestation, shall be entered in the upper line of columns 6 to 10 of the table, this being the boxes marked with EIA-1, EVA-B1 or EVA-S1 and CEM-11 and CEM-12 in the

example below.

The dates when samples were taken for repeat laboratory testing as required in accordance with point (e)(ii) of this attestation or point (e)(iii) of this attestation shall be entered in the lower line of columns 6 to 10 in table, this being the boxes EIA-2, EVA-B2 or EVA-S2 and CEM-21 and CEM-22 in the example below.

Identification of semen	Test programme	Start Date	Date of sampling for health tests
Donor residence	Semen collection	(*) VS point (b) of AH/A781A	EIA point (d)(i) of AH/A725A	EVA point (d)(ii) of AH/A725A	CEM point (d)(iii) of AH/A725A
Blood sample	Semen sample	Semen sample 1	Semen sample 2
A	B	C	D	VS	EIA-1	EVA-B1	EVA-S1	CEM-11	CEM-12
EIA-2	EVA-B2	EVA-S2	CEM-21	CEM-22

AH/A781A Animal requirements (freedom from disease)

(a) Regionalisation in accordance with Article 13 of Directive 2009/156.

For African Horse Sickness: it is not considered to be infected in accordance with Article 5(2)(a) and (b) of Directive 2009/156.

(b) (ii):

The donor stallions were subjected to a virus neutralisation test for vesicular stomatitis (VS) carried out at a serum dilution of 1 in 32 or a VS ELISA carried out in accordance with the relevant Chapter of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the WOAH.

Insert date when blood sample was taken in the table in point (f) AH/A725.

AH/P463 Product requirements

Point (b) – Insert names and concentrations.

AH/P551D Product requirements (storage and transport)

GB requirements

(a) In compliance with the requirements of Chapters II(I)(1) and III(I) of Annex D to Directive 92/65;

(b) In accordance with point 1.4 of Chapter III(I) of Annex D to Directive 92/65 and bearing the number indicated in Box I.23.

(†) The document(s) referred to above can be found at:

EU and EFTA countries approved to export animals and animal products to Great Britain (Available at: https://www.data.gov.uk/dataset/4698a65d-1a3b-42d1-981e-df869e04185b/eu-and-efta-countries-approved-to-export-animals-and-animal-products-to-great-britain)

Non-EU countries approved to export animals and animal products to Great Britain (Available at: https://www.data.gov.uk/dataset/b92627b0-dd7b-4e1d-ba36-e25424f55eeb/non-eu-countries-approved-to-export-animals-and-animal-products-to-great-britain)